Patient Resources

1. Home
2. Patient Resources
3. Health Videos

Get Healthy!

Health News Videos

Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis

• April 9, 2025
• HealthDayTV HealthDay Reporter

Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.

Multiple SclerosisBrain

Health News is provided as a service to Sav-Mor Drugs site users by HealthDay. Sav-Mor Drugs nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2026 HealthDay All Rights Reserved.

Share

---

Tags

Multiple SclerosisBrain